Charles River Laboratories | CRL - 营业利润

股票价格
166.97
每天变化
3.13 1.91%
每月一次
-3.21%
每年
42.84%
Q2 预测
166.17


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.4B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


营业利润 更改 日
Agilent USD 353M 90M 2025-12
Align Technology USD 178.05M 46.66M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Cardinal Health USD 861M 98M 2026-03
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cigna USD 2.76B 204M 2026-03
Concord Medical Services Hldg CNY -144.65M 69.38M 2025-06
CVS Health USD 2.11B 836M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Elevance Health USD -5.81B 6.39B 2026-03
Galapagos EUR 780.56M 822.23M 2025-12
Humana USD 1.75B 2.56B 2026-03
Illumina USD 256M 6M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Lonza CHF 673M 243M 2025-06
McKesson USD 1.66B 159M 2025-12
Merck EUR 474M 738M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.65B 3.99B 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Revvity USD 145.83M 47.49M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
United Therapeutics USD -14.6M 403.9M 2025-12
UnitedHealth USD 9.04B 5.78B 2026-03
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 270.52M 78.4M 2025-12
West Pharmaceutical Services USD 177.1M 14.6M 2026-03